RAAV2-ND4 ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
302Leber hereditary optic neuropathy2

302. Leber hereditary optic neuropathy


Clinical trials : 22 Drugs : 16 - (DrugBank : 4) / Drug target genes : 5 - Drug target pathways : 33
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03153293
(ClinicalTrials.gov)
December 27, 201710/5/2017A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic NeuropathyA Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic NeuropathyLeber Hereditary Optic NeuropathyDrug: rAAV2-ND4Huazhong University of Science and TechnologyShiyan Taihe HospitalActive, not recruiting10 Years65 YearsAll159Phase 2/Phase 3China
2NCT01267422
(ClinicalTrials.gov)
April 201127/12/2010Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic NeuropathyLeber Hereditary Optic NeuropathyDrug: rAAV2-ND4Bin LiHuazhong University of Science and TechnologyCompleted8 Years60 YearsAll9N/AChina